SB 435 — Maryland
Public Health - Medetomidine and Xylazine Consumer Protection Act
This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.
Maryland legislative agenda & upcoming votes Maryland session calendar
Summary
- SB 435 is a bill in the Maryland Senate, 2026 session, introduced January 30, 2026.
- Sponsored by Folden.
- Current status: introduced.
- Most recent action (April 13, 2026): Motion Laid Over (Senator Ready) Adopted.
- Subjects: Age, Comptroller, Consumer Protection, Controlled Dangerous Substances, Drugs, Health.
-
State Senator, District 4
Republican
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Folden
History
- Introduced, completed
- Passed Senate, in progress
- Passed House of Delegates, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Senate First Reading Finance
- Senate Hearing 2/11 at 2:00 p.m.
- Senate Favorable with Amendments Report by Finance
- Senate Favorable with Amendments {
- Senate Motion Laid Over (Senator Ready) Adopted Latest